Joseph Cafone

Allergy and Immunology

Stony Brook University Dept Of Pediatrics
Hsc 11
Stony Brook, NY 11794

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study.

Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study.

Journal: Journal of the American Academy of Dermatology

Published: February 24, 2026

Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial.

Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial.

Journal: Journal of the American Academy of Dermatology

Published: February 20, 2026

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

Journal: NEJM evidence

Published: January 27, 2026

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.

Journal: The New England journal of medicine

Published: November 05, 2025

Perioperative Anaphylaxis: A Systematic Approach to Evaluate High-Risk Drug Allergy.

Perioperative Anaphylaxis: A Systematic Approach to Evaluate High-Risk Drug Allergy.

Journal: Case reports in critical care

Published: August 06, 2024

A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.

A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.

Journal: Clinical pharmacology and therapeutics

Published: November 14, 2023

Increasing Cefazolin Use for Perioperative Antibiotic Prophylaxis in Penicillin-Allergic Children.

Increasing Cefazolin Use for Perioperative Antibiotic Prophylaxis in Penicillin-Allergic Children.

Journal: Pediatrics

Published: July 01, 2021

The Role of Eosinophils in Immunotherapy.

The Role of Eosinophils in Immunotherapy.

Journal: Current allergy and asthma reports

Published: January 09, 2020

Delayed Food Reaction Unresponsive to Epinephrine: A Difficult Case of FPIES.

Delayed Food Reaction Unresponsive to Epinephrine: A Difficult Case of FPIES.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 04, 2019

The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy.

The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: July 31, 2019

Eosinophilic esophagitis during sublingual and oral allergen immunotherapy.

Eosinophilic esophagitis during sublingual and oral allergen immunotherapy.

Journal: Current opinion in allergy and clinical immunology

Published: May 07, 2019

A 57-Year-Old Woman on Rituximab Presenting With Fever and Lethargy.

A 57-Year-Old Woman on Rituximab Presenting With Fever and Lethargy.

Journal: Chest

Published: June 20, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026